SCHEMBL1600562

SCHEMBL1600562

CC(C)(CCC#N)CN(C[C@@H](OC(=O)C(F)(F)F)[C@@H](N)Cc1ccccc1)S(=O)(=O)c1ccc2c(c1)OCO2

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.38
TAS2R14 Q9NYV8 1/20 0.37
MAPT P10636 4/20 0.37
LMNA P02545 3/20 0.37
GAA P10253 2/20 0.37
BMP1 P13497 2/20 0.37
MEP1B Q16820 1/20 0.36
HPGD P15428 1/20 0.35
HTT P42858 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
KEAP1 Q14145 1/20 0.34
NFE2L2 Q16236 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
SPPL2A Q8TCT8 1/20 0.34
NPC1 O15118 1/20 0.34
POLB P06746 1/20 0.34
RAB9A P51151 1/20 0.34
TSHR P16473 1/20 0.33
MAPK1 P28482 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12734839 0.86 SPPL2A (0.47) ALDH1A1TAS2R14MAPTLMNAGAA
Hydrochloric Acid SCHEMBL1602148 0.85 SPPL2A (0.47) ALDH1A1TAS2R14MAPTLMNAGAA
SCHEMBL12709319 0.81 SPPL2A (0.40) ALDH1A1TAS2R14MAPTLMNAGAA
SCHEMBL12735016 0.81 SPPL2A (0.40) ALDH1A1TAS2R14MAPTLMNAGAA
SCHEMBL4149300 0.79 BMP1 (0.39) ALDH1A1TAS2R14MAPTLMNAGAA
SCHEMBL4165957 0.79 SPPL2A (0.41) ALDH1A1TAS2R14MAPTLMNAGAA
SCHEMBL1602077 0.78 SPPL2A (0.47) ALDH1A1MAPTLMNAGAAHPGD
SCHEMBL4347242 0.78 SPPL2A (0.41) ALDH1A1TAS2R14LMNABMP1MEP1B
SCHEMBL12734840 0.78 SPPL2A (0.44) ALDH1A1LMNASPPL2A
SCHEMBL13950812 0.78 SPPL2A (0.44) ALDH1A1LMNASPPL2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7919523-B2 Inhibitors of aspartyl protease VERTEX PHARMACEUTICALS, INC. (US) 2011-04-05 US disclosed
US-6617350-B2 Sulfonamides which are aspartyl protease inhibitors; well suited for inhibiting HIV-1 and HIV-2 protease activity VERTEX PHARMACEUTICALS INCORPORATED 2003-09-09 US disclosed